Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,628 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02443428 | Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry | completed | — | 77 | Eisai LimitedINDUSTRY | 3 | Apr 15, 2016 | clinicaltrials |
| NCT01980134 | The MORDIS Study Clinical Investigational Plan(MORDIS) | unknown | — | 1,200 | SpectraScienceOTHER | 5 | Apr 14, 2016 | clinicaltrials |
| NCT02150772 | The Diagnostic Value of Shear Wave Elastography | completed | N/A | 308 | University of AarhusOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT00338247 | EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer | approved for marketing | — | — | NovartisINDUSTRY | 45 | Apr 6, 2016 | clinicaltrials |
| NCT01523132 | Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms | completed | — | 545 | Rigshospitalet, DenmarkOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT02381912 | Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer | completed | — | 210 | Herlev HospitalOTHER | 1 | Mar 9, 2016 | clinicaltrials |
| NCT01025804 | Pharmacokinetics of Asparaginase and Antibody Formation in Interfant-06 | completed | — | 15 | Aarhus University HospitalOTHER | 5 | Mar 4, 2016 | clinicaltrials |
| NCT02686775 | The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients(PACO) | unknown | N/A | 306 | Danish Cancer SocietyOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT02167087 | Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.(SENSE) | completed | N/A | 30 | Ismail GögenürOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01888419 | Investigation of the Pain Relieving Properties of Lipotransplantation After Treatment for Breast Cancer | completed | N/A | 18 | Aarhus University HospitalOTHER | 1 | Feb 15, 2016 | clinicaltrials |
| NCT01697072 | First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma(RILOMET-1) | terminated | Phase 3 | 609 | AmgenINDUSTRY | 27 | Feb 9, 2016 | clinicaltrials |
| NCT00554229 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases(ENTHUSE M1) | completed | Phase 3 | 896 | AstraZenecaINDUSTRY | 31 | Feb 8, 2016 | clinicaltrials |
| NCT01640262 | Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup | completed | — | 170 | Copenhagen University Hospital at HerlevOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT01761721 | Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics(RALH) | completed | — | 139 | Copenhagen University Hospital at HerlevOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT02020291 | Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer | completed | Phase 1 | 31 | WntResearch ABINDUSTRY | 1 | Feb 2, 2016 | clinicaltrials |
| NCT00812266 | Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) | terminated | Phase 3 | 281 | Danish Oncological Lung Cancer GroupOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02457390 | The Value of CE-LUS During Robot-assisted Surgery for Primary Colorectal Cancer(CE-LUS) | completed | N/A | 50 | Odense University HospitalOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02659332 | Laser Treatment of Bladder Tumors in the Outpatient Department | unknown | N/A | 20 | Gregers G HermannOTHER | 1 | Jan 21, 2016 | clinicaltrials |
| NCT01287637 | Early Closure of Temporary Ileostomy(EASY) | completed | N/A | 89 | Herlev HospitalOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT01784406 | Person-centred Support for Women After Treatment for Gynaecological Cancer(PESU) | completed | N/A | 165 | Rigshospitalet, DenmarkOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT00639054 | The Molecular Characterization of Multiple Myeloma at Relapse(MM-FISH/DNA) | completed | — | 134 | Rigshospitalet, DenmarkOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT02646462 | Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer | unknown | — | 200 | Michael Bau MortensenOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT02023359 | Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer | completed | — | 7 | Novartis Healthcare A/SINDUSTRY | 1 | Dec 29, 2015 | clinicaltrials |
| NCT00225641 | Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer | unknown | N/A | 2,500 | Bispebjerg HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01670851 | Perineal Reconstruction Following eLAPE and Simultaneous Stoma Sublay Reinforcement(PRESSUR) | completed | — | 20 | University Hospitals, LeicesterOTHER | 3 | Dec 8, 2015 | clinicaltrials |
| NCT02109861 | Microdose Study of Melphalan, Bortezomib and Dexamethasone(Phase-0-MM) | unknown | Early Phase 1 | 6 | Henrik GregersenOTHER | 1 | Dec 8, 2015 | clinicaltrials |
| NCT02624440 | Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma(SUTRICA) | unknown | Phase 2 | 300 | Henrik GregersenOTHER | 1 | Dec 8, 2015 | clinicaltrials |
| NCT00389155 | First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy | completed | Phase 2 / Phase 3 | 34 | Bristol-Myers SquibbINDUSTRY | 16 | Dec 7, 2015 | clinicaltrials |
| NCT00609843 | Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer | completed | N/A | 5 | University of AarhusOTHER | 1 | Dec 7, 2015 | clinicaltrials |
| NCT00381836 | Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer | terminated | Phase 2 / Phase 3 | 140 | University of AarhusOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT01404520 | Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)(PACE-AL) | completed | N/A | 70 | Universitetshospitalernes Center for SygeplejeOTHER | 1 | Dec 2, 2015 | clinicaltrials |
| NCT02583126 | Guided Imagery and Music for the Reduction of Side Effects of Chemotherapy in Teenagers | unknown | N/A | 68 | University of AarhusOTHER | 1 | Dec 2, 2015 | clinicaltrials |
| NCT01831466 | Tofacitinib Ointment For Chronic Plaque Psoriasis | completed | Phase 2 | 476 | PfizerINDUSTRY | 4 | Nov 25, 2015 | clinicaltrials |
| NCT00409188 | Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)(START) | completed | Phase 3 | 1,513 | EMD SeronoINDUSTRY | 33 | Nov 20, 2015 | clinicaltrials |
| NCT02207686 | Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease? | unknown | — | 50 | Marie Luise Bisgaard, MDOTHER | 1 | Nov 13, 2015 | clinicaltrials |
| NCT00594984 | Phase I/II Combination With Irinotecan- Erbitux | completed | Phase 1 / Phase 2 | 38 | Bristol-Myers SquibbINDUSTRY | 7 | Nov 4, 2015 | clinicaltrials |
| NCT02592304 | Preoperative Assessment of Mesorectal Lymph Nodes by Dual Energy CT. PUMK-DECT | unknown | N/A | 70 | Odense University HospitalOTHER | 1 | Oct 30, 2015 | clinicaltrials |
| NCT00511459 | Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients | completed | Phase 2 | 228 | AmgenINDUSTRY | 13 | Oct 29, 2015 | clinicaltrials |
| NCT02102646 | MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | completed | Phase 4 | 31 | Herlev HospitalOTHER | 1 | Oct 28, 2015 | clinicaltrials |
| NCT01048762 | Multidisciplinary Rehabilitation After Cancer Pulmonis Operation | completed | Phase 2 | 78 | Aalborg University HospitalOTHER | 1 | Oct 22, 2015 | clinicaltrials |
| NCT00548561 | Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines | completed | Phase 2 / Phase 3 | 23 | Valerio TherapeuticsINDUSTRY | 1 | Oct 21, 2015 | clinicaltrials |
| NCT00548704 | A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines | completed | Phase 2 / Phase 3 | 57 | Valerio TherapeuticsINDUSTRY | 5 | Oct 21, 2015 | clinicaltrials |
| NCT01042028 | A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 39 | Per PfeifferOTHER | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00612664 | Phase II, 2nd Line Melanoma - RAND Monotherapy | completed | Phase 2 | 158 | Bristol-Myers SquibbINDUSTRY | 6 | Oct 12, 2015 | clinicaltrials |
| NCT00229697 | Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study | completed | Phase 2 | 317 | AstraZenecaINDUSTRY | 12 | Oct 5, 2015 | clinicaltrials |
| NCT02068950 | Progressive Resistance Training Program in Head and Neck Cancer Patients | completed | N/A | 12 | Herlev HospitalOTHER | 1 | Sep 25, 2015 | clinicaltrials |
| NCT00973427 | DNA Chip Based Prognosis of Lung Cancer | completed | — | 144 | Medical Prognosis Institute A/SINDUSTRY | 2 | Sep 23, 2015 | clinicaltrials |
| NCT01216930 | Molecular Screening for Lynch Syndrome in Southern Denmark | completed | — | 2,000 | Vejle HospitalOTHER | 1 | Sep 14, 2015 | clinicaltrials |
| NCT01045915 | Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma(AMEP) | terminated | Phase 1 | 5 | Valerio TherapeuticsINDUSTRY | 3 | Sep 11, 2015 | clinicaltrials |
| NCT00256932 | Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | completed | Phase 3 | 518 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 10 | Sep 2, 2015 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials